For the year ending 2025-12-31, INMB has $32,351K in assets. $8,827K in debts. $24,751K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 24,751 | |||
| Research and development tax credit receivable | 4,284 | |||
| Other tax receivable | 257 | |||
| Prepaid expenses and other current assets | 595 | |||
| Total current assets | 29,887 | |||
| Equipment, net | 955 | |||
| Operating lease right of use asset | 914 | |||
| Other assets | 595 | |||
| Total assets | 32,351 | |||
| Accounts payable and accrued liabilities | 7,768 | |||
| Accounts payable and accrued liabilities related parties | 25 | |||
| Operating lease, current liability | 623 | |||
| Total current liabilities | 8,416 | |||
| Long-term operating lease liability | 411 | |||
| Total liabilities | 8,827 | |||
| Common stock, 0.001 par value, 200,000,000 shares authorized, 26,585,258 and 22,280,451 shares issued and outstanding, respectively | 27 | |||
| Additional paid-in capital | 233,271 | |||
| Accumulated other comprehensive loss | -737 | |||
| Accumulated deficit | -209,037 | |||
| Total stockholders equity | 23,524 | |||
| Total liabilities and stockholders equity | 32,351 | |||
Inmune Bio, Inc. (INMB)
Inmune Bio, Inc. (INMB)